The one-stage method was carried out on several hundred subjects to find the limits of variation in nonhypoprothrombinemic states. As representative samples, the results on 12 normal subjects studied ...

Thirteen patients with liver disease and an abnormal prothrombin time refractory to vitamin K therapy were studied (Tables 1 and 2). None of the patients were actively bleeding, and none had received ...

The prothrombin gene mutation increases your risk of severe blood clots. Medications, regular checkups, and healthy lifestyle habits can help reduce this risk. The prothrombin gene plays a crucial ...